ISS Backs Kenvue (KVUE) Deal, Investors Debate Tylenol and Litigation Risks [Yahoo! Finance]
Kenvue Inc. (KVUE)
Company Research
Source: Yahoo! Finance
Kenvue Inc. (NYSE:KVUE) is looking to potentially reshape the consumer health landscape, as it received institutional support for its proposed merger with Kimberly-Clark. On January 16, 2026, Reuters reported that Institutional Shareholder Services (ISS), a proxy advisory firm, recommended that shareholders approve Kimberly-Clark's $40 billion bid for Kenvue. The firm believes the merger could deliver positive synergies and advance strategic objectives, despite uncertainties surrounding ongoing talcum litigation and concerns regarding Tylenol's active ingredient. Meanwhile, Meridian Hedged Equity Fund discussed Kenvue Inc. (NYSE:KVUE) in its Q3 2025 investor letter, highlighting the market's overreaction to the Tylenol safety concerns. The firm noted minimal revenue impact from pregnant women, no new scientific evidence, and largely dismissed litigation claims. In fact, the fund believes the company could unlock significant value if it reinvests in underfunded brands, optimizes cos
Show less
Read more
Impact Snapshot
Event Time:
KVUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KVUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KVUE alerts
High impacting Kenvue Inc. news events
Weekly update
A roundup of the hottest topics
KVUE
News
- Kenvue (NYSE:KVUE) had its "hold (c-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Here's What Impacted Kenvue's (KVUE) in Q3 [Yahoo! Finance]Yahoo! Finance
- Share Offerings Prompt Huge Insider Buying in These 3 Biotechs [Yahoo! Finance]Yahoo! Finance
- GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities [Seeking Alpha]Seeking Alpha
- Halper Sadeh LLC Encourages GDOT, KVUE, RPTX, KMB Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
KVUE
Earnings
- 11/3/25 - Beat
KVUE
Sec Filings
- 1/16/26 - Form 425
- 1/16/26 - Form 425
- 1/16/26 - Form 8-K
- KVUE's page on the SEC website